This analysis reveals altered gray matter volume and cerebral blood flow in chronic kidney disease, suggesting reduced cognitive function in affected individuals.
Motivation: Chronic kidney disease (CKD) can lead to cognitive impairment, but its underlying mechanisms remain unclear. Goal(s): This study investigates gray matter volume (GMV) and cerebral blood flow (CBF) changes across CKD stages, identifies co-altered brain regions, and examines abnormal seed-based functional connectivity (FC) correlations with MoCA scores. Approach: We recruited 208 participants (66 healthy controls, 70 CKD stages 1-3a, and 72 CKD stages 3b-5) for high-resolution T1-weighted imaging, arterial spin labeling, and functional MRI. Results: The CKD 3b-5 group exhibited reduced GMV and increased CBF in fusiform gyrus, decreased FC with cognitive-related regions, and negative correlations with MoCA scores. Impact: Alterations in brain structure and perfusion may contribute to reduced FC between the fusiform gyrus and cognitive-related regions, offering neuroimaging evidence for the neuropathological mechanisms of cognitive impairment in different stages of CKD.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: